Evidence map›Paper›PMID 35243140›Full record

ArticleAmerican journal of ophthalmology case reports2022

Multimodal treatment of Coats-like exudative vitreoretinopathy in Goldmann-Favre syndrome.

Fabiola Ramos Nieves, Victor M Villegas, Nimesh A Patel, Audina M Berrocal, Timothy G Murray

Open access · goldAbstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Coats disease presenting with vitreous hemorrhage and neovascular glaucoma.American journal of ophthalmology case reports · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Fabiola Ramos NievesDepartment of Ophthalmology, University of Puerto Rico School of Medicine, University of Puerto Rico, Medical Sciences Campus, PO BOX 365067, San Juan, PR, 00936-5067, USA.
Victor M VillegasDepartment of Ophthalmology, University of Puerto Rico School of Medicine, University of Puerto Rico, Medical Sciences Campus, PO BOX 365067, San Juan, PR, 00936-5067, USA.
Nimesh A PatelBascom Palmer Eye Institute, University of Miami, Miami, FL, USA.
Audina M BerrocalDepartment of Ophthalmology, Harvard Medical School, and Retina Service, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA, 02114, USA.
Timothy G MurrayMurray Ocular Oncology and Retina (MOOR), Miami, FL, USA.
Massachusetts Eye and Ear Infirmary · USUniversity of Miami · USUniversity of Puerto Rico, Medical Sciences Campus · PR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo report a Coats-like exudative vitreoretinopathy in Goldmann-Favre syndrome. OBSERVATIONS: A 64 year-old woman with prior diagnosis of retinal dystrophy presented with decreased vision in the right eye (OD). Ophthalmologic examination was remarkable for bilateral arteriolar attenuation, mid-peripheral bony-spicules, and waxy disc pallor. Coats-like exudative vitreoretinopathy and cystoid macular edema were present OD. Genetic testing showed a homozygous pathogenic mutation in gene CONCLUSIONS AND IMPORTANCE: A Coats-like exudative vitreoretinopathy may occur in the setting of Goldmann-Favre syndrome. Targeted laser ablation in combination with intravitreal therapy can be efficacious in select patients.

Indexed as

BevacizumabCoats diseaseGoldmann-FavreIntravitreal therapyTriamcinolone acetonide

Identifiers

PMID35243140
PMCPMC8859797
OpenAlexW4210752575

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.